ScreenerHero

VIRO ViroGates A/S

CPH · DK · Healthcare · Medical Devices · virogates.com
8.500DKK-8.60%Mkt Cap: 11.49M $P/E: —

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidime…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc. - Common Stock
$32.21BUSDP/E 33.7
GEHC
GE HealthCare Technologies Inc. - Common Stock
$29.24BUSDP/E 14.8
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
TXG
10x Genomics, Inc. - Common Stock
$12.18BUSD
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
GKOS
Glaukos Corporation
$9.67BUSD

Key Statistics

Company
Market Cap11.49M USD
Enterprise Value10.58M USD
Revenue (TTM)1.36M USD
Gross Profit964.36K USD
Net Income (TTM)-1.51M USD
Revenue/Share1.01 DKK
Last Price8.500 DKK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7
CountryDK
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue7.76
P/S9.22
P/B5.33
EPS (TTM)-0.88
EPS (Forward)—
52W Range
7.6009% of range17.40
52W High17.40 DKK
52W Low7.600 DKK
Profitability
Gross Margin74.36%
Oper. Margin-26.65%
EBITDA Margin0.00%
Profit Margin-116.77%
ROE-53.58%
ROA-33.99%
Growth
Revenue Growth9.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-600.82K USD
CapEx (TTM)—
FCF Margin-108.94%
FCF Yield-12.93%
Net Debt-2.00M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.24
Current Ratio6.90
Quick Ratio6.23
Book Value/Sh1.75 DKK
Cash/Share1.90 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 DKK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.28M
Float2.37M
Insiders74.50%
Institutions0.00%
Technical
SMA 5010.32 (-17.6%)
SMA 20010.99 (-22.7%)
Beta0.60
S&P 52W Chg14.58%
Avg Vol (30d)1.88K
Avg Vol (10d)3.16K
Technical Indicators
RSI (14)44.4
MACD-0.3924
MACD Signal-0.2111
MACD Hist.-0.1813
BB Upper11.59 DKK
BB Middle10.10 DKK
BB Lower8.618 DKK
BB Width29.38%
ATR (14)0.7420 DKK
Vol Ratio (20d)1.52x